Isabella Presch: From Innovation to Accessibility in Cell and Gene Therapy
Isabella Presch, Senior Medical Director Rare diseases, Advanced therapies and Pediatrics at Fortrea, shared a post on LinkedIn:
“Kicking off day 3 ESGCT 2026 European Society of Gene and Cell Therapy with a session focusing on accessibility to cell and gene therapies
Cornelis Boersma about Healthcare systems fit for cell and gene therapies:
Sustainable access to health care innovation requires:
- Better alignment between registration authorities and HTA bodies
- An opportunity-based (value) instead of a purely risk-based (price) approach
- Transition from one-off assessment to dynamic systems
Invest in possibilities.
Transformation towards sustainable decision-making systems following a patient-centric and outcomes-based approach
Prof. Dr. Christopher Baum highlighted Europe’s amazing portfolio of CGT platform technologies analyzing status quo and how to jointly address the entire value chain possibilistic
‘Possibilism designates… positions that foreground possibility (what could be) over necessity (what must be) or exclusive attention to actuality (what is). … Requires taking the space of alternatives seriously, rather than treating the actual as … inevitable”
Other posts featuring Isabella Presch on Hemostatis Today.
-
Oct 30, 2026, 14:00Abdul Mannan: A Negative PCR Does Not Exclude β-Thalassaemia
-
Oct 30, 2026, 13:53Matteo Foschi: Can Thrombolysis Safely Treat Stroke After Cardiac Procedures?
-
Oct 30, 2026, 13:42Wolfgang Miesbach: Gene Therapy-Associated Leukaemia With Clonal Persistence Over 16 Years
-
Oct 30, 2026, 12:47Louise St. Germain Bannon: Turning Thrombosis Awareness into Stroke Prevention
-
Oct 30, 2026, 12:36Aryabhatta Sadhu: Sickle Cell Crisis Recognising When Treatment Must Change
-
Oct 30, 2026, 12:22Fabrice Cognasse: The Future of Blood Banks From Transfusion Support to Precision Medicine
-
Oct 30, 2026, 12:09Carmelo Gurnari: Clonal Dynamics in the Bone Marrow During Sepsis and Emergency Haematopoiesis
-
Oct 30, 2026, 11:49Advancing Global Care for Hemophilia and Bleeding Disorders – World Federation of Hemophilia
-
Oct 30, 2026, 05:18Flora Peyvandi: Molecular and Lab Markers Linked to Bleeding Severity in Factor VII Deficiency